Car-T Therapy in Action
Helping the body’s immune system recognize and attack cancer cells
CAR-T Therapy supporting the body’s immune system more effectively
The Tailored Genes team is helping lead the next wave of CAR-T innovation by delivering viral vectors built for performance, consistency, and real-world transduction outcomes. Our work supports the engineering of T cells for advanced cell therapy programs, helping research teams move faster, reduce variability, and build with confidence from early development through scale-up.
Developing High Quality Technology for CAR-T Therapy
CAR-T development depends on consistent gene delivery into T cells to achieve predictable expression and function. High-quality viral vectors help reduce variability, improve transduction outcomes, and support scalable workflows, making them essential for reliable R&D, process development, and next-generation cell therapy advancement.
Reliable transduction performance
We focus on functional outcomes, not just “high numbers”.
Collaborative, project-based support
We work like a partner, not just a vendor, responsive communication matters.
Experience supporting advanced cell therapy workflows
We understand the pace, pressure, and precision required in CAR-T development.
Lentiviral + AAV capability
We support the vectors commonly used across gene and cell therapy research.
AAV Services
How Does CAR-T Therapy Work?
CAR-T therapy uses a patient’s own immune cells, which are modified in a lab to find and attack cancer cells more effectively.
01.
T-cells are collected
Doctors collect T cells from a patient’s blood
02.
The cells are engineered
In a specialized lab, those T cells are modified to include a new receptor (the CAR). That new receptor helps the cells recognize a specific target on cancer cells.
03.
The engineered T-cells are expanded
Once the cells have been modified, they’re grown and multiplied to create enough cells for treatment.
04.
The CAR-T cells are infused back into the patient
The upgraded T cells go back into the patient’s body.
05.
The CAR-T cells hunt cancer cells
Now, instead of missing the cancer, the engineered cells can find it and attack it more efficiently.
Vector Quality Matters in CAR-T Research and Development
CAR-T programs require precision.
When researchers are building therapies that may eventually be used in humans, they need tools that perform consistently and predictably.
Reliable vectors help support:
- Strong transduction efficiency
- Consistent expression
- Reproducible results across experiments
- Faster troubleshooting and development timelines
In other words:
Good science needs good delivery.
Why Choose Us for your CART–T Project
We provide end-to-end support for your CAR-T project, combining advanced technology, strict quality standards, and experienced professionals to ensure reliable and efficient results. Our commitment to innovation, compliance, and timely delivery helps bring your cell therapy solutions to market with confidence.
- North American Manufacturing – this ensures strict quality standards.
- Fast Turnaround Times – We deliver projects quickly and efficiently, ensuring you get what you need without unnecessary delays.
- Satisfaction Guarantee – We follow up after delivery to ensure the stable cell lines meet your expectations. If issues arise, we’ll work with you to resolve them.
Our Solutions
Explore More Manufacturing Solutions
Expertly crafted virus vectors and cell line solutions—powering research from bench to breakthrough.
Adeno-Associated Virus (AAV)
High titer (10¹³ and 10¹⁴ GC/mL) and ultra pure AAV vectors.
Lentivirus Vectors
High titer (10⁸–10⁹ IU/mL) and high purity LV vectors.
Covid-19 Vectors
Safe vectors with variant COVID-19 spikes to study entry and test antivirals.
